Beyond Barriers

Redefining Intracellular Therapeutic Delivery

Step into a world where every cell is reached and every therapy’s impact is enhanced.

Follow us

The Challenges of Current Drug Delivery Systems

Low Delivery Rate

Most of the therapeutic load never reaches their intracellular target

Toxicity Barrier

High toxicity and side effects limit therapeutic potential

Unmet Medical Needs

Many cancers and rare disorders lack effective treatments

A Revolutionary Solution:
GEENIE Technology

CyGenica's GEENIE technology delivers 100% of therapeutic molecules directly to the cell's interior.

GEENIE is a groundbreaking, engineered protein nanoneedle with a cell entry mechanism that is unique. By completely bypassing the endosomes, GEENIE ensures precise and efficient delivery of a wide range of therapeutics, from nucleotides to proteins. This next-generation technology redefines what’s possible in intracellular drug delivery.

Dr. Eoin Fleming- University College Cork

Collaborated with Dr. Fleming, sponsored a student for Masters and PhD studies to support research on novel protein chimeras for targeted delivery of therapeutic proteins and nucleotides.

Dr. Frances Cleary- Walton Institute, Waterford Institute of Technology

Collaborated on EVAPORATE (Exploring a Data-Driven Approach to Personalised Cancer Therapies), using computational modelling to reduce drug-induced neurotoxicity.

Dr. Abhijit De- Advanced Centre for Treatment, Research, and Education in Cancer (ACTREC)

Collaborated with the Molecular Functional Imaging Lab on biodistribution studies in mice, by whole-animal imaging using the IVIS system.

Dr. Eoin Fleming- University College Cork

Collaborated with Dr. Fleming, sponsored a student for Masters and PhD studies to support research on novel protein chimeras for targeted delivery of therapeutic proteins and nucleotides.

Dr. Frances Cleary- Walton Institute, Waterford Institute of Technology

Collaborated on EVAPORATE (Exploring a Data-Driven Approach to Personalised Cancer Therapies), using computational modelling to reduce drug-induced neurotoxicity.

Dr. Abhijit De- Advanced Centre for Treatment, Research, and Education in Cancer (ACTREC)

Collaborated with the Molecular Functional Imaging Lab on biodistribution studies in mice, by whole-animal imaging using the IVIS system.

Let’s Shape the Future of Therapeutics – Together!

We’re looking for visionary biopharmaceutical partners to join us in transforming intracellular drug delivery. With our breakthrough GEENIE technology, we’re unlocking new possibilities for advanced therapies.